Skip to main content
. Author manuscript; available in PMC: 2020 Sep 1.
Published in final edited form as: Mol Carcinog. 2019 May 16;58(9):1670–1679. doi: 10.1002/mc.23044

Table 2 –

Analysis variable: Sex

Group N Obs Female Male
Healthy 49 25 (51.02%) 24 (48.98%)
Melanoma 49 25 (51.02%) 24 (48.98%)
 Stage 0 5 4 (80.00%) 1 (20.00%)
 Stage I 18 11 (61.11%) 7 (38.89%)
 Stage II 10 5 (50.00%) 5 (50.00%)
 Stage III 6 3 (50.00%) 3 (50.00%)
 Stage IV 10 2 (20.00%) 8 (80.00%)